All News

Independent pharmacists should tune in to this webinar event to learn how Good Neighbor Pharmacy's 4 core value centers can help them optimize their business.

Interim analysis results from a phase 3 clinical trial reported a vaccine efficacy rate above 90% for BNT162b2. The trial is ongoing until it meets its threshold for confirmed COVID-19 cases.

Pharmacies are seeing an increased demand for flu vaccines in the first season that coincides with the coronavirus pandemic.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."

Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.

CMS’ new plan will ensure coverage of COVID-19 vaccines with no out-of-pocket costs, while increasing the number of providers that will administer the vaccine.

Kroger Health is offering rapid antibody testing for coronavirus disease 2019 (COVID-19) across all its pharmacies and clinics by the end of November.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.

Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

CVS Health is hiring more than 10,000 full-time and part-time pharmacy technicians to meet the demand for flu vaccinations and, in the future, coronavirus disease 2019 (COVID-19) vaccinations.

Policymakers have the power to get pharmacy benefit managers under control.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.

Here's the coronavirus-related news from this week that you should know.

The approval, which was based on the PALM randomized controlled trial, is the first FDA-approved treatment for Ebola virus infection.

If anything has demonstrated the need and value of expanded access to community-based care, it’s been the coronavirus disease 2019 pandemic.

A new report from the National Academies of Sciences, Engineering, and Medicine include pharmacists in the priority group for receiving the COVID-19 vaccine when available.

Apomorphine hydrochloride (Kynmobi; Sunovion) is a sublingual therapy for the acute intermittent treatment of off episodes in patients with Parkinson disease.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” on Tuesday, October 13, 2020 at 6 PM EDT.

Rutledge v. Pharmaceutical Care Management Association seeks to clarify whether states can regulate pharmacy benefit managers.

New policy recommendations aim to increase the uptake of biomarker testing and advance health insurance coverage for precision medicine in cancer care.

Every year, Drug Topics® asks pharmacists about their job experiences. Take our 2020 Annual Pharmacy Salary Survey here.

What happens next in health care depends largely on COVID-19, especially in light of the breaking news that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

Watch some of the highlights from the virtually-held ThoughtSpot 2020 conference and trade show.

SingleCare's "Best of the Best" Pharmacy Awards honors pharmacists and pharmacy technicians, the COVID-19 pandemic's unsung health care heroes.

Tofacitinib (Xeljanz; Pfizer) is the first and only Janus kinase inhibitor approved in the US for this indication.

Members of the MJH Life Sciences COVID-19 Coalition weighed in on the latest pandemic information in a recent survey.

The FDA is requiring an update to the boxed warning on all benzodiazepines and new labeling.